Krishna Yeshwant

Insider Reports History

Entity
Individual
Location
C/O Google Ventures 2011, L.P., 1600 Amphitheatre Parkway, Mountain View, CA
Signature
/s/ Andrew Ashe, as Attorney-in-Fact for Krishna Yeshwant
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Krishna Yeshwant:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verve Therapeutics, Inc. Director, 10%+ Owner Common Stock 6.11M $61.1M $10.00 Dec 1, 2023 By GV 2017 L.P.
Verve Therapeutics, Inc. Director, 10%+ Owner Common Stock 4.26M $42.6M $10.00 Dec 1, 2023 By GV 2019 L.P.
Verve Therapeutics, Inc. Director, 10%+ Owner Common Stock 1.8M $18M $10.00 Dec 1, 2023 By GV 2023, L.P.
Verve Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 136K Jun 26, 2024 Direct
EQRx, Inc. Director Stock Option (Right to Buy) 0 Nov 9, 2023 Direct

Insider Reports Filed by Krishna Yeshwant

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VERV Verve Therapeutics, Inc. Jun 26, 2024 1 $0 4 Jun 28, 2024 Director, 10%+ Owner
VERV Verve Therapeutics, Inc. Dec 1, 2023 1 $18M 4 Dec 5, 2023 Director, 10%+ Owner
EQRX EQRx, Inc. Nov 9, 2023 1 $0 4 Nov 9, 2023 Director
VERV Verve Therapeutics, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director, 10%+ Owner
VERV Verve Therapeutics, Inc. Nov 4, 2022 4 -$1.51M 4 Nov 8, 2022 Director, 10%+ Owner
VERV Verve Therapeutics, Inc. Nov 2, 2022 8 -$2.66M 4 Nov 4, 2022 Director, 10%+ Owner
VERV Verve Therapeutics, Inc. Oct 31, 2022 9 -$3.25M 4 Nov 2, 2022 Director, 10%+ Owner
EQRX EQRx, Inc. Sep 30, 2022 1 $0 4 Oct 4, 2022 Director
VERV Verve Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director, 10%+ Owner
EQRX EQRx, Inc. Dec 17, 2021 0 $0 3 Dec 20, 2021 Director
VERV Verve Therapeutics, Inc. Jun 21, 2021 6 $0 4 Jun 22, 2021 Director, 10%+ Owner
VERV Verve Therapeutics, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 Director, 10%+ Owner